Market Overview:
The global BGM and CGM market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetes management, and technological advancements in BGM and CGM devices. Based on type, the global BGM and CGM market is segmented into BGMs and CGMs. The BGMs segment is further sub-segmented into traditional BGMs and continuous glucose monitoring (CMG) devices. The CGMs segment is further sub-segmented into standalone CGMs and integrated CGMs. Based on application, the global BGM and CGM market is divided into two segments: hospital applicationsand household applications. Geographically, the global B GMandCG Mmarketis dividedinto five regions: North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
BGM is Background Music and CGM is Continuous Glucose Monitoring. BGM can be used in a variety of ways but it most commonly refers to the music that plays in the background of a scene or movie. This music can be used to create a specific mood or feeling, set the tone for the scene, and help to engage the viewer. CGM is a system that continuously monitors blood sugar levels by testing tiny amounts of blood from under the skin. It provides information about glucose levels every 5 minutes which helps people with diabetes better manage their disease.
BGM:
BGM (Body-gated Microphone) is a device implanted in the body which helps people with hearing disabilities to amplify and understand speech. BGM works on the principle of sound amplification by means of a microphone placed inside the body. It is usually used for deaf people as it enables them to hear sounds which are beyond human hearing range.
CGM:
It helps in monitoring the patient’s progress during treatment with medications. The most common uses of CGM are in measuring myocardial perfusion, left ventricular volume and function, right ventricular volume & function, vascular resistance, intraventricular pressure and pulmonary venous return.
Application Insights:
The global market is segmented by application into hospital, household and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing prevalence of diabetes and rising awareness about blood glucose monitoring among patients suffering from diabetes at hospitals across the globe. Moreover, an increase in healthcare spending by consumers is also expected to fuel demand for CGM devices over the forecast period.
The household application segment accounted for a significant share of more than 30% in 2017 owing to high adoption rates among people with diabetes and their families worldwide due to improved glycemic control observed with BGM use at home along with other benefits such as convenience, flexibility and cost-effectiveness over conventional care settings.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through 2030, owing to factors such as increasing prevalence of diabetes and obesity, rising adoption of bariatric surgery for obese patients with obesity, growing geriatric population prone to chronic diseases such as diabetes and cardiovascular diseases (CVDs), high healthcare expenditure levels, well-established healthcare infrastructure & availability of highly skilled physicians.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving economic conditions leading towards overall improvement in health status; rapid urbanization resulting into increased demand for medical services; increase in disposable income that would lead towards an increase in demand for medical products & services including bgm and cgm systems; rise in aging population at a risk of developing various chronic diseases that may require long term care & monitoring which will further boost the regional market growth.
Growth Factors:
- Increasing prevalence of diabetes and obesity: The global prevalence of diabetes is expected to increase from 9% in 2010 to 11% by 2030. This will create a larger pool of patients who will require treatment, including those requiring BGM and CGM devices. Obesity rates are also increasing, which will further drive demand for these devices.
- Advances in technology: Technological advances are making BGM and CGM devices smaller, more accurate, and easier to use. This is helping to broaden their appeal among patients and physicians alike, driving market growth.
- Growing awareness about the benefits of BGM/CGM: There is growing awareness among both patients and healthcare professionals about the benefits of using BGM/CGM devices for diabetes management. This is helping to boost demand for these products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
BGM and CGM Market Research Report
By Type
BGM, CGM
By Application
Hospital, Household
By Companies
Roche, LifeScan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, AgaMatrix, ALL Medicus, Terumo, Sinocare, Yicheng, Yuwell, Acon, Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global BGM and CGM Market Report Segments:
The global BGM and CGM market is segmented on the basis of:
Types
BGM, CGM
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Household
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- LifeScan
- Abbott
- Ascensia
- ARKRAY
- I-SENS
- Omron
- B. Braun
- 77 Elektronika
- AgaMatrix
- ALL Medicus
- Terumo
- Sinocare
- Yicheng
- Yuwell
- Acon
- Dexcom
- Medtronic
- Senseonics Holdings
- GlySens Incorporated
Highlights of The BGM and CGM Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BGM
- CGM
- By Application:
- Hospital
- Household
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the BGM and CGM Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
BGM is background music, and CGM is continuous glucose monitoring.
Some of the key players operating in the bgm and cgm market are Roche, LifeScan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun, 77 Elektronika, AgaMatrix, ALL Medicus, Terumo, Sinocare, Yicheng, Yuwell, Acon, Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated.
The bgm and cgm market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 BGM and CGM Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 BGM and CGM Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 BGM and CGM Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the BGM and CGM Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global BGM and CGM Market Size & Forecast, 2020-2028
4.5.1 BGM and CGM Market Size and Y-o-Y Growth
4.5.2 BGM and CGM Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 BGM
5.2.2 CGM
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Household
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global BGM and CGM Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 BGM and CGM Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 BGM
9.6.2 CGM
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Household
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 BGM
10.6.2 CGM
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Household
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 BGM
11.6.2 CGM
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Household
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 BGM
12.6.2 CGM
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Household
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 BGM
13.6.2 CGM
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Household
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 BGM and CGM Market: Competitive Dashboard
14.2 Global BGM and CGM Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 LifeScan
14.3.3 Abbott
14.3.4 Ascensia
14.3.5 ARKRAY
14.3.6 I-SENS
14.3.7 Omron
14.3.8 B. Braun
14.3.9 77 Elektronika
14.3.10 AgaMatrix
14.3.11 ALL Medicus
14.3.12 Terumo
14.3.13 Sinocare
14.3.14 Yicheng
14.3.15 Yuwell
14.3.16 Acon
14.3.17 Dexcom
14.3.18 Medtronic
14.3.19 Senseonics Holdings
14.3.20 GlySens Incorporated
